文献
J-GLOBAL ID:201802276759422811
整理番号:18A0817587
チロシンキナーゼ阻害剤クリゾチニブは,FOXO転位を伴う進行性肺胞横紋筋肉腫を有する重度前治療患者において臨床的に有意な活性を有しない: 癌第2相試験の研究と治療のためのヨーロッパ組織 第2回試験【JST・京大機械翻訳】
The tyrosine kinase inhibitor crizotinib does not have clinically meaningful activity in heavily pre-treated patients with advanced alveolar rhabdomyosarcoma with FOXO rearrangement: European Organisation for Research and Treatment of Cancer phase 2 trial 90101 ‘CREATE’
著者 (16件):
Schoffski Patrick
(Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium)
,
Schoffski Patrick
(Department of Oncology, Laboratory of Experimental Oncology, KU Leuven, Leuven, Belgium)
,
Wozniak Agnieszka
(Department of Oncology, Laboratory of Experimental Oncology, KU Leuven, Leuven, Belgium)
,
Leahy Michael G.
(The Christie NHS Foundation Trust, Manchester, UK)
,
Aamdal Steinar
(Department of Oncology, Oslo University Hospital, Oslo, Norway)
,
Rutkowski Piotr
(Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland)
,
Bauer Sebastian
(Department of Internal Medicine, West German Cancer Center, University Hospital, University of Duisburg-Essen, Germany and German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany)
,
Richter Stephan
(University Hospital Carl Gustav Carus, University Cancer Center/Medical Dpt. I, Dresden, Germany)
,
Gruenwald Viktor
(Clinic for Haematology, Haemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany)
,
Debiec-Rychter Maria
(Department of Human Genetics, KU Leuven and University Hospitals Leuven, Leuven, Belgium)
,
Sciot Raf
(Department of Pathology, University Hospitals Leuven, Leuven, Belgium)
,
Geoerger Birgit
(Department of Pediatric and Adolescent Oncology, Gustave Roussy, Villejuif, France)
,
Marreaud Sandrine
(European Organization for Research and Treatment of Cancer, Brussels, Belgium)
,
Collette Sandra
(European Organization for Research and Treatment of Cancer, Brussels, Belgium)
,
Nzokirantevye Axelle
(European Organization for Research and Treatment of Cancer, Brussels, Belgium)
,
Strauss Sandra J.
(Department of Oncology, University College London Hospitals NHS Trust, London, UK)
資料名:
European Journal of Cancer
(European Journal of Cancer)
巻:
94
ページ:
156-167
発行年:
2018年
JST資料番号:
A0802C
ISSN:
0959-8049
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)